<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p224" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_224{left:35px;bottom:24px;letter-spacing:-0.34px;word-spacing:0.13px;}
#t2_224{left:306px;bottom:30px;}
#t3_224{left:313px;bottom:24px;letter-spacing:0.16px;}
#t4_224{left:346px;bottom:30px;}
#t5_224{left:351px;bottom:24px;letter-spacing:-0.16px;word-spacing:-0.22px;}
#t6_224{left:517px;bottom:30px;}
#t7_224{left:524px;bottom:24px;letter-spacing:-0.28px;word-spacing:-0.09px;}
#t8_224{left:288px;bottom:860px;letter-spacing:0.11px;word-spacing:-0.55px;}
#t9_224{left:288px;bottom:829px;letter-spacing:0.27px;word-spacing:-0.69px;}
#ta_224{left:1115px;bottom:27px;letter-spacing:0.23px;}
#tb_224{left:35px;bottom:777px;letter-spacing:0.07px;word-spacing:0.12px;}
#tc_224{left:35px;bottom:757px;letter-spacing:0.16px;}
#td_224{left:396px;bottom:757px;}
#te_224{left:35px;bottom:722px;letter-spacing:0.03px;word-spacing:0.15px;}
#tf_224{left:35px;bottom:702px;letter-spacing:0.01px;word-spacing:-0.69px;}
#tg_224{left:35px;bottom:683px;letter-spacing:-0.05px;word-spacing:0.24px;}
#th_224{left:35px;bottom:665px;letter-spacing:0.06px;word-spacing:-0.98px;}
#ti_224{left:35px;bottom:645px;letter-spacing:-0.07px;word-spacing:0.25px;}
#tj_224{left:180px;bottom:645px;letter-spacing:0.16px;}
#tk_224{left:549px;bottom:645px;}
#tl_224{left:35px;bottom:608px;letter-spacing:0.04px;word-spacing:0.14px;}
#tm_224{left:35px;bottom:589px;letter-spacing:0.04px;word-spacing:-1.09px;}
#tn_224{left:35px;bottom:570px;letter-spacing:0.07px;word-spacing:0.12px;}
#to_224{left:35px;bottom:551px;letter-spacing:0.09px;word-spacing:0.1px;}
#tp_224{left:35px;bottom:531px;letter-spacing:0.16px;}
#tq_224{left:396px;bottom:531px;}
#tr_224{left:35px;bottom:495px;letter-spacing:0.06px;word-spacing:0.13px;}
#ts_224{left:35px;bottom:476px;letter-spacing:0.17px;word-spacing:0.02px;}
#tt_224{left:35px;bottom:457px;letter-spacing:0.01px;word-spacing:-0.65px;}
#tu_224{left:35px;bottom:437px;letter-spacing:0.01px;word-spacing:0.18px;}
#tv_224{left:35px;bottom:418px;letter-spacing:0.07px;word-spacing:0.12px;}
#tw_224{left:35px;bottom:398px;letter-spacing:0.16px;}
#tx_224{left:396px;bottom:398px;}
#ty_224{left:35px;bottom:363px;letter-spacing:0.08px;word-spacing:-0.91px;}
#tz_224{left:35px;bottom:343px;letter-spacing:0.05px;word-spacing:-0.09px;}
#t10_224{left:35px;bottom:324px;letter-spacing:0.08px;word-spacing:0.1px;}
#t11_224{left:35px;bottom:304px;letter-spacing:0.16px;}
#t12_224{left:405px;bottom:304px;}
#t13_224{left:35px;bottom:269px;letter-spacing:0.02px;word-spacing:0.17px;}
#t14_224{left:35px;bottom:249px;letter-spacing:0.06px;word-spacing:-0.94px;}
#t15_224{left:35px;bottom:229px;letter-spacing:0.07px;word-spacing:0.12px;}
#t16_224{left:35px;bottom:210px;letter-spacing:0.06px;word-spacing:0.13px;}
#t17_224{left:35px;bottom:190px;letter-spacing:0.1px;word-spacing:0.09px;}
#t18_224{left:35px;bottom:171px;letter-spacing:0.16px;}
#t19_224{left:396px;bottom:171px;}
#t1a_224{left:35px;bottom:135px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1b_224{left:35px;bottom:116px;letter-spacing:0.02px;word-spacing:0.17px;}
#t1c_224{left:35px;bottom:96px;letter-spacing:0.05px;word-spacing:0.14px;}
#t1d_224{left:35px;bottom:78px;letter-spacing:0.1px;word-spacing:0.09px;}
#t1e_224{left:35px;bottom:58px;letter-spacing:0.16px;}
#t1f_224{left:405px;bottom:58px;}
#t1g_224{left:618px;bottom:777px;letter-spacing:0.08px;word-spacing:0.1px;}
#t1h_224{left:618px;bottom:759px;letter-spacing:0.01px;word-spacing:0.17px;}
#t1i_224{left:618px;bottom:739px;letter-spacing:0.02px;word-spacing:0.16px;}
#t1j_224{left:618px;bottom:720px;letter-spacing:0.11px;word-spacing:-0.19px;}
#t1k_224{left:618px;bottom:700px;letter-spacing:-0.07px;word-spacing:0.25px;}
#t1l_224{left:763px;bottom:700px;letter-spacing:0.16px;}
#t1m_224{left:1132px;bottom:700px;}
#t1n_224{left:618px;bottom:665px;letter-spacing:0.09px;word-spacing:0.1px;}
#t1o_224{left:618px;bottom:645px;letter-spacing:0.12px;word-spacing:0.06px;}
#t1p_224{left:618px;bottom:625px;letter-spacing:0.04px;word-spacing:0.15px;}
#t1q_224{left:618px;bottom:606px;letter-spacing:0.1px;word-spacing:-0.22px;}
#t1r_224{left:618px;bottom:586px;letter-spacing:0.11px;word-spacing:0.08px;}
#t1s_224{left:618px;bottom:567px;letter-spacing:0.16px;}
#t1t_224{left:988px;bottom:567px;}
#t1u_224{left:618px;bottom:531px;letter-spacing:0.07px;word-spacing:0.11px;}
#t1v_224{left:618px;bottom:512px;letter-spacing:0.11px;word-spacing:0.07px;}
#t1w_224{left:618px;bottom:492px;letter-spacing:0.01px;word-spacing:0.17px;}
#t1x_224{left:618px;bottom:473px;letter-spacing:0.08px;word-spacing:0.11px;}
#t1y_224{left:618px;bottom:453px;letter-spacing:0.16px;}
#t1z_224{left:988px;bottom:453px;}
#t20_224{left:618px;bottom:418px;letter-spacing:0.07px;word-spacing:-0.5px;}
#t21_224{left:618px;bottom:398px;letter-spacing:0.04px;word-spacing:0.15px;}
#t22_224{left:618px;bottom:379px;letter-spacing:0.24px;word-spacing:-0.05px;}
#t23_224{left:618px;bottom:359px;letter-spacing:-0.23px;word-spacing:1.63px;}
#t24_224{left:715px;bottom:359px;letter-spacing:0.16px;}
#t25_224{left:1084px;bottom:359px;}
#t26_224{left:618px;bottom:324px;letter-spacing:0.14px;word-spacing:0.05px;}
#t27_224{left:618px;bottom:304px;letter-spacing:0.16px;word-spacing:0.03px;}
#t28_224{left:618px;bottom:284px;letter-spacing:0.11px;word-spacing:0.08px;}
#t29_224{left:618px;bottom:266px;letter-spacing:0.08px;word-spacing:0.1px;}
#t2a_224{left:618px;bottom:247px;letter-spacing:0.16px;}
#t2b_224{left:979px;bottom:247px;}
#t2c_224{left:618px;bottom:210px;letter-spacing:0.1px;word-spacing:0.09px;}
#t2d_224{left:618px;bottom:190px;letter-spacing:0.1px;word-spacing:0.09px;}
#t2e_224{left:618px;bottom:172px;letter-spacing:0.13px;word-spacing:0.06px;}
#t2f_224{left:618px;bottom:152px;letter-spacing:0.05px;word-spacing:0.13px;}
#t2g_224{left:618px;bottom:133px;letter-spacing:0.16px;}
#t2h_224{left:988px;bottom:133px;}
#t2i_224{left:618px;bottom:96px;letter-spacing:0.09px;word-spacing:0.09px;}
#t2j_224{left:618px;bottom:78px;letter-spacing:0.04px;word-spacing:0.14px;}
#t2k_224{left:618px;bottom:58px;letter-spacing:0.1px;word-spacing:0.08px;}
#t2l_224{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_224{font-size:10px;font-family:ArialMT_5tg;color:#000;}
.s1_224{font-size:6px;font-family:ArialMT_5tg;color:#000;}
.s2_224{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s3_224{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_224{font-size:17px;font-family:ArialMT_5tg;color:#000;}
.s5_224{font-size:17px;font-family:ArialMT_5tg;color:#005B99;}
.s6_224{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts224" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg224Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg224" style="-webkit-user-select: none;"><object width="1210" height="935" data="224/224.svg" type="image/svg+xml" id="pdf224" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_224" class="t s0_224">Version 4.2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t2_224" class="t s1_224">© </span>
<span id="t3_224" class="t s0_224">(NCCN </span>
<span id="t4_224" class="t s1_224">© </span>
<span id="t5_224" class="t s0_224">), All rights reserved. NCCN Guidelines </span>
<span id="t6_224" class="t s1_224">® </span>
<span id="t7_224" class="t s0_224">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="t8_224" class="t s2_224">NCCN Guidelines Version 4.2024 </span>
<span id="t9_224" class="t s2_224">Head and Neck Cancers </span>
<span id="ta_224" class="t s3_224">MS-83 </span>
<span id="tb_224" class="t s4_224">larynx preservation. J Natl Cancer Inst 2009;101:498-506. Available at: </span>
<span id="tc_224" class="t s5_224">http://www.ncbi.nlm.nih.gov/pubmed/19318632</span><span id="td_224" class="t s4_224">. </span>
<span id="te_224" class="t s4_224">304. Blanchard P, Bourhis J, Lacas B, et al. Taxane-cisplatin-fluorouracil </span>
<span id="tf_224" class="t s4_224">as induction chemotherapy in locally advanced head and neck cancers: an </span>
<span id="tg_224" class="t s4_224">individual patient data meta-analysis of the meta-analysis of </span>
<span id="th_224" class="t s4_224">chemotherapy in head and neck cancer group. J Clin Oncol 2013;31:2854- </span>
<span id="ti_224" class="t s4_224">2860. Available at: </span><span id="tj_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/23835714</span><span id="tk_224" class="t s4_224">. </span>
<span id="tl_224" class="t s4_224">305. Hitt R, Grau JJ, Lopez-Pousa A, et al. A randomized phase III trial </span>
<span id="tm_224" class="t s4_224">comparing induction chemotherapy followed by chemoradiotherapy versus </span>
<span id="tn_224" class="t s4_224">chemoradiotherapy alone as treatment of unresectable head and neck </span>
<span id="to_224" class="t s4_224">cancer. Ann Oncol 2014;25:216-225. Available at: </span>
<span id="tp_224" class="t s5_224">http://www.ncbi.nlm.nih.gov/pubmed/24256848</span><span id="tq_224" class="t s4_224">. </span>
<span id="tr_224" class="t s4_224">306. Haddad R, O'Neill A, Rabinowits G, et al. Induction chemotherapy </span>
<span id="ts_224" class="t s4_224">followed by concurrent chemoradiotherapy (sequential </span>
<span id="tt_224" class="t s4_224">chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally </span>
<span id="tu_224" class="t s4_224">advanced head and neck cancer (PARADIGM): a randomised phase 3 </span>
<span id="tv_224" class="t s4_224">trial. Lancet Oncol 2013;14:257-264. Available at: </span>
<span id="tw_224" class="t s5_224">http://www.ncbi.nlm.nih.gov/pubmed/23414589</span><span id="tx_224" class="t s4_224">. </span>
<span id="ty_224" class="t s4_224">307. Cohen EE, Karrison TG, Kocherginsky M, et al. Phase III randomized </span>
<span id="tz_224" class="t s4_224">trial of induction chemotherapy in patients with N2 or N3 locally advanced </span>
<span id="t10_224" class="t s4_224">head and neck cancer. J Clin Oncol 2014;32:2735-2743. Available at: </span>
<span id="t11_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/25049329</span><span id="t12_224" class="t s4_224">. </span>
<span id="t13_224" class="t s4_224">308. Paccagnella A, Ghi MG, Loreggian L, et al. Concomitant </span>
<span id="t14_224" class="t s4_224">chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil </span>
<span id="t15_224" class="t s4_224">(TPF) followed by concomitant chemoradiotherapy in locally advanced </span>
<span id="t16_224" class="t s4_224">head and neck cancer: a phase II randomized study. Ann Oncol </span>
<span id="t17_224" class="t s4_224">2010;21:1515-1522. Available at: </span>
<span id="t18_224" class="t s5_224">http://www.ncbi.nlm.nih.gov/pubmed/20032123</span><span id="t19_224" class="t s4_224">. </span>
<span id="t1a_224" class="t s4_224">309. Ghi MG, Paccagnella A, Ferrari D, et al. Induction TPF followed by </span>
<span id="t1b_224" class="t s4_224">concomitant treatment versus concomitant treatment alone in locally </span>
<span id="t1c_224" class="t s4_224">advanced head and neck cancer. A phase II-III trial. Ann Oncol </span>
<span id="t1d_224" class="t s4_224">2017;28:2206-2212. Available at: </span>
<span id="t1e_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/28911070</span><span id="t1f_224" class="t s4_224">. </span>
<span id="t1g_224" class="t s4_224">310. Wanebo HJ, Lee J, Burtness BA, et al. Induction cetuximab, </span>
<span id="t1h_224" class="t s4_224">paclitaxel, and carboplatin followed by chemoradiation with cetuximab, </span>
<span id="t1i_224" class="t s4_224">paclitaxel, and carboplatin for stage III/IV head and neck squamous </span>
<span id="t1j_224" class="t s4_224">cancer: a phase II ECOG-ACRIN trial (E2303). Ann Oncol 2014;25:2036- </span>
<span id="t1k_224" class="t s4_224">2041. Available at: </span><span id="t1l_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/25009013</span><span id="t1m_224" class="t s4_224">. </span>
<span id="t1n_224" class="t s4_224">311. Dietz A, Wichmann G, Kuhnt T, et al. Induction chemotherapy (IC) </span>
<span id="t1o_224" class="t s4_224">followed by radiotherapy (RT) versus cetuximab plus IC and RT in </span>
<span id="t1p_224" class="t s4_224">advanced laryngeal/hypopharyngeal cancer resectable only by total </span>
<span id="t1q_224" class="t s4_224">laryngectomy-final results of the larynx organ preservation trial DeLOS-II. </span>
<span id="t1r_224" class="t s4_224">Ann Oncol 2018;29:2105-2114. Available at: </span>
<span id="t1s_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/30412221</span><span id="t1t_224" class="t s4_224">. </span>
<span id="t1u_224" class="t s4_224">312. Specenier PM, Remenar E, Buter J, et al. TPF plus cetuximab </span>
<span id="t1v_224" class="t s4_224">induction chemotherapy followed by biochemoradiation with weekly </span>
<span id="t1w_224" class="t s4_224">cetuximab plus weekly cisplatin or carboplatin: a randomized phase II </span>
<span id="t1x_224" class="t s4_224">EORTC trial. Ann Oncol 2017;28:2219-2224. Available at: </span>
<span id="t1y_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/28911062</span><span id="t1z_224" class="t s4_224">. </span>
<span id="t20_224" class="t s4_224">313. Haddad RI, Posner M, Hitt R, et al. Induction chemotherapy in locally </span>
<span id="t21_224" class="t s4_224">advanced squamous cell carcinoma of the head and neck: role, </span>
<span id="t22_224" class="t s4_224">controversy, and future directions. Ann Oncol 2018;29:1130-1140. </span>
<span id="t23_224" class="t s4_224">Available at: </span><span id="t24_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/29635316</span><span id="t25_224" class="t s4_224">. </span>
<span id="t26_224" class="t s4_224">314. Lefebvre JL, Pointreau Y, Rolland F, et al. Induction chemotherapy </span>
<span id="t27_224" class="t s4_224">followed by either chemoradiotherapy or bioradiotherapy for larynx </span>
<span id="t28_224" class="t s4_224">preservation: the TREMPLIN randomized phase II study. J Clin Oncol </span>
<span id="t29_224" class="t s4_224">2013;31:853-859. Available at: </span>
<span id="t2a_224" class="t s5_224">http://www.ncbi.nlm.nih.gov/pubmed/23341517</span><span id="t2b_224" class="t s4_224">. </span>
<span id="t2c_224" class="t s4_224">315. Janoray G, Pointreau Y, Alfonsi M, et al. Induction chemotherapy </span>
<span id="t2d_224" class="t s4_224">followed by cisplatin or cetuximab concomitant to radiotherapy for </span>
<span id="t2e_224" class="t s4_224">laryngeal/hypopharyngeal cancer: Long-term results of the TREMPLIN </span>
<span id="t2f_224" class="t s4_224">randomised GORTEC trial. Eur J Cancer 2020;133:86-93. Available at: </span>
<span id="t2g_224" class="t s5_224">https://www.ncbi.nlm.nih.gov/pubmed/32454417</span><span id="t2h_224" class="t s4_224">. </span>
<span id="t2i_224" class="t s4_224">316. Hitt R, Mesia R, Lozano A, et al. Randomized phase 3 noninferiority </span>
<span id="t2j_224" class="t s4_224">trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after </span>
<span id="t2k_224" class="t s4_224">docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with </span>
<span id="t2l_224" class="t s6_224">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
